Abstract
The 2018 Family Planning Market Report covers the total FP2020 public sector market– defined as volumes purchased by institutional buyers (USAID, UNFPA, Social Marketing Organizations, etc.) and Ministry of Health (MOH) or government-affiliated procurers for the 69 FP2020 focus countries1. The report covers all product-based modern methods based on historical supplier-reported shipment data collected from 14 suppliers2 for female condoms, implants, injectables, IUDs, orals (combined and progestin only), and emergency oral contraceptives. Findings for male condoms are based on data from the Reproductive Health Interchange.
COMPARED TO 20113, THE VALUE OF THE FP2020 PUBLIC SECTOR MARKET4 IN 2017 SAW A CONTINUATION OF THE DOWNWARD TREND EVIDENCED SINCE 2011. THIS SUBSTANTIAL DECLINE OVER THIS SIX-YEAR PERIOD IS PRIMARILY DRIVEN BY AN OVERALL DECREASE IN THE SHIPMENTS OF ORALS (COMBINED AND PROGESTIN ONLY) AND INJECTABLES5, AND, TO SOME EXTENT, OFFSET BY AN INCREASE IN SHIPMENTS OF IMPLANTS.
CYPs6 SHIPPED DECLINED AT A SIMILAR RATE OVER THE SAME PERIOD, DRIVEN MAINLY BY A DECREASE IN IUDs AND ORALs (COMBINED AND PROGESTIN ONLY) AND SOMEWHAT OFFSET BY AN INCREASE IN IMPLANTS.
